Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: Results from the Costa Rica Vaccine Trial

Background: We investigated the role of antibody responses as potential mechanism for the cross-protective vaccine-efficacies (VE) observed from randomized clinical trials of the HPV16/18 bivalent vaccine. Results: HPV31 cases had lower HPV16 antibody levels than controls (OR(4th quartile compared w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Safaeian, Mahboobeh, Kemp, Troy J., Pan, David Yuanji, Porras, Carolina, Rodriguez, Ana Cecilia, Schiffman, Mark, Cortes, Bernal, Katki, Hormuzd, Wacholder, Sholom, Schiller, John T., Gonzalez, Paula, Penrose, Kerri, Lowy, Douglas R., Quint, Wim, van Doorn, Leen-Jan, Herrero, Rolando, Hildesheim, Allan, Pinto, Ligia A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Landes Bioscience 2013
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3974884/
https://ncbi.nlm.nih.gov/pubmed/23571174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.24340
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller